retatrutide fatty liver disease nonalcoholic trial Retatrutide in Canada: Clinical Results, Cost Expectations, and Patient Experience Retatrutide: A deep dive Part

Unlike earlier GLP-1 receptor agonists such as semaglutide, retatrutide is what scientists call a "triple agonist" because it simultaneously activates three different hormone receptors in your body

GLP-1, or glucagon-like peptide-1, is a hormone that plays a vital role in regulating blood sugar levels

A LOT by over 63% including a 73% decrease in fast food visits

Pick an anchor compound

real-world patient outcomes, e.g., weight loss achieved, its durability, impact on CV risk factors, safety and tolerability

Mazdutide adds glucagon receptor activation, which introduces an energy expenditure and fat oxidation component that Semaglutide lacks